Russell Frank Company’s AstraZeneca AZN Stock Holding History

Russell Frank Company’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$1.73M	Sell	30,644 -515	-2%	-$30.9K	﹤0.01%	1923
2015 Q4	$2.15M	Sell	31,159 -126	-0.4%	-$8.26K	﹤0.01%	1800
2015 Q3	$1.99M	Sell	31,285 -4,097	-12%	-$270K	﹤0.01%	1836
2015 Q2	$2.25M	Buy	35,382 +13,532	+62%	+$926K	﹤0.01%	1898
2015 Q1	$1.5M	Sell	21,850 -18,144	-45%	-$1.26M	﹤0.01%	1944
2014 Q4	$2.83M	Sell	39,994 -50,770	-56%	-$3.64M	﹤0.01%	1589
2014 Q3	$6.48M	Sell	90,764 -2,074	-2%	-$152K	0.01%	1126
2014 Q2	$6.78M	Sell	92,838 -12,445	-12%	-$900K	0.01%	1149
2014 Q1	$8.17M	Sell	105,283 -13,584	-11%	-$877K	0.01%	1001
2013 Q4	$7.07M	Sell	118,867 -39,707	-25%	-$2.16M	0.01%	1036
2013 Q3	$8.23M	Sell	158,574 -4,620	-3%	-$232K	0.01%	1015
2013 Q2	$7.72M	Buy	+163,194	New	+$8.31M	0.01%	983

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Russell Frank Company's AZN Position: Q1 2016 in Review

Russell Frank Company reduced its AstraZeneca (AZN) stake by 1.7% in Q1 2016, selling an estimated $30.9K and leaving 30,644 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1923.

Russell Frank Company first reported a position in AZN in Q2 2013 and has held it in 12 quarters since. The position peaked at $8.23M in Q3 2013. 390 funds tracked by Wall St. Rank hold AZN as of Q1 2016.

Russell Frank Company held 30,644 shares of AstraZeneca worth $1.73M as of Q1 2016.
Russell Frank Company sold 515 AstraZeneca shares in Q1 2016, an estimated $30.9K.
AstraZeneca made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #1923 holding.
Russell Frank Company first reported a position in AstraZeneca in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's AstraZeneca position peaked at $8.23M in Q3 2013.
390 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.